NICE has rejected the use of AstraZeneca and Daiichi Sankyo’s Enhertu as an NHS treatment for advanced HER2-low breast cancer, a decision that the companies have described as “devastating”. The ...

In arguments that ranged from classic cars to Western omelets, key conservative justices seemed open to the government's argument that kits allowing people to make nearly untraceable guns at home can ...